Targeting metastatic upper gastrointestinal adenocarcinomas

doi:10.5306/wjco.v2.i3.135

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6692)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

382

HTML

5739

Figures (1-3)

267

Tables (1-2)

304

Sum=6692

Mar 10, 2011 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Clin Oncol. Mar 10, 2011; 2(3): 135-149
Published online Mar 10, 2011. doi: 10.5306/wjco.v2.i3.135

Table 2 Antiangiogenic agents in upper gastrointestinal malignancies

Drug	Mechanism of action	Applicable tumor sites
Bevacizumab	Intravenous recombinant humanized monoclonal antibody against VEGF	Gastric
		Hepatocellular
		Biliary tract
		Pancreas
Sunitinib	Oral multitargeted TKI inhibiting VEGFR-1, VEGFR-2, PDGFR-β, c-KIT, FLT3, and RET	Gastric
Sunitinib		Hepatocellular
Sorafenib	Oral multitargeted TKI inhibiting VEGFR-1, VEGFR-2, PDGFR-β, Raf-1, B-Raf, and intracellular serine-threonine kinases	Gastric
		Hepatocellular
		Pancreas

VEGF: Vascular endothelial growth factor; VEGFR: Vascular endothelial growth factor receptor; TKI: Tyrosine kinase inhibitor; PDGFR: Platelet-derived growth factor receptors.

Citation: Spratlin JL, Chu Q, Koski S, King K, Mulder K. Targeting metastatic upper gastrointestinal adenocarcinomas. World J Clin Oncol 2011; 2(3): 135-149
URL: https://www.wjgnet.com/2218-4333/full/v2/i3/135.htm
DOI: https://dx.doi.org/10.5306/wjco.v2.i3.135